iMerciv Accepted into CTA Silicon Valley Fall 2019 Cohort

iMerciv was accepted into the Fall 2019 Cohort of the Canadian Technology Accelerator in Silicon Valley, which helps high-potential Canadian technology companies access the unique resources of Silicon Valley to grow at a global scale.

Click here to learn more about the CTA Silicon Valley

EC6_xP7X4AA_vgB.jpg
Previous
Previous

FedDev Ontario announces $6.24 million investment in OBIO

Next
Next

Profound Medical Announces U.S. FDA 510(k) Clearance for TULSA-PRO®